PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.40%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-29.55%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-62.46%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-62.46%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-63.67%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-65.79%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-64.86%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
2.06%
Share reduction more than 1.5x LSCC's 6.26%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-12.19%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-2.02%
Dividend reduction while LSCC stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-81.83%
Negative OCF growth while LSCC is at 1406.41%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-145.60%
Negative FCF growth while LSCC is at 1684.12%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
9.31%
10Y revenue/share CAGR under 50% of LSCC's 344.27%. Michael Burry would suspect a lasting competitive disadvantage.
-19.03%
Negative 5Y CAGR while LSCC stands at 71.63%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
1.93%
3Y revenue/share CAGR under 50% of LSCC's 60.01%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
72.96%
10Y OCF/share CAGR under 50% of LSCC's 606.14%. Michael Burry would worry about a persistent underperformance in cash creation.
241.61%
5Y OCF/share CAGR at 75-90% of LSCC's 309.23%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
333.18%
3Y OCF/share CAGR above 1.5x LSCC's 181.69%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
403.33%
Net income/share CAGR above 1.5x LSCC's 230.67% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
20.89%
Positive 5Y CAGR while LSCC is negative. John Neff might view this as a strong mid-term relative advantage.
1743.73%
Positive short-term CAGR while LSCC is negative. John Neff would see a clear advantage in near-term profit trajectory.
305.24%
Below 50% of LSCC's 760.90%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
163.29%
5Y equity/share CAGR 1.25-1.5x LSCC's 142.09%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
91.82%
3Y equity/share CAGR 1.25-1.5x LSCC's 76.22%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
5.40%
Dividend/share CAGR of 5.40% while LSCC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-0.94%
Negative 5Y dividend/share CAGR while LSCC stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-1.13%
Negative near-term dividend growth while LSCC invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-11.62%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-4.30%
Inventory is declining while LSCC stands at 17.91%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.70%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.20%
Positive BV/share change while LSCC is negative. John Neff sees a clear edge over a competitor losing equity.
-6.60%
We’re deleveraging while LSCC stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
1.13%
We increase R&D while LSCC cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-13.22%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.